JP2008504279A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008504279A5 JP2008504279A5 JP2007518300A JP2007518300A JP2008504279A5 JP 2008504279 A5 JP2008504279 A5 JP 2008504279A5 JP 2007518300 A JP2007518300 A JP 2007518300A JP 2007518300 A JP2007518300 A JP 2007518300A JP 2008504279 A5 JP2008504279 A5 JP 2008504279A5
- Authority
- JP
- Japan
- Prior art keywords
- aryl
- membered
- carbonyl
- cyclopropyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000003118 aryl group Chemical group 0.000 claims 51
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 46
- 125000000753 cycloalkyl group Chemical group 0.000 claims 45
- 125000000217 alkyl group Chemical group 0.000 claims 34
- 150000001875 compounds Chemical class 0.000 claims 32
- 125000005843 halogen group Chemical group 0.000 claims 29
- 125000001072 heteroaryl group Chemical group 0.000 claims 28
- 125000003545 alkoxy group Chemical group 0.000 claims 24
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 21
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 21
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims 20
- 229910005965 SO 2 Inorganic materials 0.000 claims 20
- 125000005466 alkylenyl group Chemical group 0.000 claims 18
- 125000004429 atom Chemical group 0.000 claims 18
- 125000004432 carbon atom Chemical group C* 0.000 claims 16
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 15
- 229910052760 oxygen Inorganic materials 0.000 claims 15
- 229910052717 sulfur Inorganic materials 0.000 claims 13
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 12
- 125000003282 alkyl amino group Chemical group 0.000 claims 12
- 229910052799 carbon Inorganic materials 0.000 claims 12
- 125000004663 dialkyl amino group Chemical group 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 12
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 12
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 10
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims 7
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 7
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 7
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 6
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000004438 haloalkoxy group Chemical group 0.000 claims 3
- 239000000651 prodrug Substances 0.000 claims 3
- 229940002612 prodrug Drugs 0.000 claims 3
- -1 4,5,6,7-tetrahydro-thieno [2,3-c] pyridinyl Chemical group 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 208000032928 Dyslipidaemia Diseases 0.000 claims 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- KCKUJDZUDDFYSH-UHFFFAOYSA-N (1-cyclohexylsulfonylcyclopropyl)-(3-phenylpiperazin-1-yl)methanone Chemical compound C1CC1(S(=O)(=O)C1CCCCC1)C(=O)N(C1)CCNC1C1=CC=CC=C1 KCKUJDZUDDFYSH-UHFFFAOYSA-N 0.000 claims 1
- ZLOMSEDPUPTGFV-UHFFFAOYSA-N (1-cyclohexylsulfonylcyclopropyl)-(3-pyridin-4-ylpyrrolidin-1-yl)methanone Chemical compound C1CC1(S(=O)(=O)C1CCCCC1)C(=O)N(C1)CCC1C1=CC=NC=C1 ZLOMSEDPUPTGFV-UHFFFAOYSA-N 0.000 claims 1
- GPVIVLBVCZAEPJ-UHFFFAOYSA-N (1-cyclohexylsulfonylcyclopropyl)-pyrrolidin-1-ylmethanone Chemical compound C1CC1(S(=O)(=O)C1CCCCC1)C(=O)N1CCCC1 GPVIVLBVCZAEPJ-UHFFFAOYSA-N 0.000 claims 1
- WZFHTXODPVKARC-UHFFFAOYSA-N (1-phenylsulfanylcyclopropyl)-spiro[1,3-dihydroindene-2,4'-piperidine]-1'-ylmethanone Chemical compound C1CC2(CC3=CC=CC=C3C2)CCN1C(=O)C1(SC=2C=CC=CC=2)CC1 WZFHTXODPVKARC-UHFFFAOYSA-N 0.000 claims 1
- ZUHOZIJDAQQDKH-UHFFFAOYSA-N (3-methyl-4-phenylpiperazin-1-yl)-(1-phenylsulfanylcyclopropyl)methanone Chemical compound CC1CN(C(=O)C2(CC2)SC=2C=CC=CC=2)CCN1C1=CC=CC=C1 ZUHOZIJDAQQDKH-UHFFFAOYSA-N 0.000 claims 1
- OZFIQFOWJRHRJW-UHFFFAOYSA-N (3-phenylpiperidin-1-yl)-(1-phenylsulfanylcyclopropyl)methanone Chemical compound C1CC1(SC=1C=CC=CC=1)C(=O)N(C1)CCCC1C1=CC=CC=C1 OZFIQFOWJRHRJW-UHFFFAOYSA-N 0.000 claims 1
- XOTXLNBANZFMAV-UHFFFAOYSA-N 1'-(1-phenylsulfanylcyclopropanecarbonyl)spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1CC2(C3=CC=CC=C3C(=O)O2)CN1C(=O)C1(SC=2C=CC=CC=2)CC1 XOTXLNBANZFMAV-UHFFFAOYSA-N 0.000 claims 1
- UQCOPIMTSBBVTD-UHFFFAOYSA-N 1'-[1-(2,6-dichlorophenyl)sulfanylcyclopropanecarbonyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound ClC1=CC=CC(Cl)=C1SC1(C(=O)N2CC3(CC2)C2=CC=CC=C2C(=O)O3)CC1 UQCOPIMTSBBVTD-UHFFFAOYSA-N 0.000 claims 1
- XQRJWZKXNWUPMX-UHFFFAOYSA-N 1'-[1-(3,4-dichlorophenyl)sulfanylcyclopropanecarbonyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1=C(Cl)C(Cl)=CC=C1SC1(C(=O)N2CC3(CC2)C2=CC=CC=C2C(=O)O3)CC1 XQRJWZKXNWUPMX-UHFFFAOYSA-N 0.000 claims 1
- IZWHHWNIHBUWPY-UHFFFAOYSA-N 1'-[1-(3,5-dichlorophenyl)sulfanylcyclopropanecarbonyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound ClC1=CC(Cl)=CC(SC2(CC2)C(=O)N2CC3(CC2)C2=CC=CC=C2C(=O)O3)=C1 IZWHHWNIHBUWPY-UHFFFAOYSA-N 0.000 claims 1
- DYMFZKQMTQQBOT-UHFFFAOYSA-N 1'-[1-(3-chloro-4-fluorophenyl)sulfanylcyclopropanecarbonyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1=C(Cl)C(F)=CC=C1SC1(C(=O)N2CC3(CC2)C2=CC=CC=C2C(=O)O3)CC1 DYMFZKQMTQQBOT-UHFFFAOYSA-N 0.000 claims 1
- GZSMZIDDJWPIMT-UHFFFAOYSA-N 1'-[1-(4-chlorophenyl)sulfanylcyclopropanecarbonyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1=CC(Cl)=CC=C1SC1(C(=O)N2CC3(CC2)C2=CC=CC=C2C(=O)O3)CC1 GZSMZIDDJWPIMT-UHFFFAOYSA-N 0.000 claims 1
- PGBVVTQCCZJNNQ-UHFFFAOYSA-N 1'-[1-(4-fluorophenyl)sulfanylcyclopropanecarbonyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1=CC(F)=CC=C1SC1(C(=O)N2CC3(CC2)C2=CC=CC=C2C(=O)O3)CC1 PGBVVTQCCZJNNQ-UHFFFAOYSA-N 0.000 claims 1
- WMWOJVODFSMTQW-UHFFFAOYSA-N 1'-[1-[3-(trifluoromethyl)phenyl]sulfanylcyclopropanecarbonyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound FC(F)(F)C1=CC=CC(SC2(CC2)C(=O)N2CC3(CC2)C2=CC=CC=C2C(=O)O3)=C1 WMWOJVODFSMTQW-UHFFFAOYSA-N 0.000 claims 1
- SXIPZUFARNSJEJ-UHFFFAOYSA-N 1'-[1-[4-(4-fluorophenyl)phenyl]sulfanylcyclopropanecarbonyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1=CC(F)=CC=C1C(C=C1)=CC=C1SC1(C(=O)N2CC3(CC2)C2=CC=CC=C2C(=O)O3)CC1 SXIPZUFARNSJEJ-UHFFFAOYSA-N 0.000 claims 1
- GMMUWWOAGPQJAM-UHFFFAOYSA-N 1'-[1-[4-(trifluoromethoxy)phenyl]sulfanylcyclopropanecarbonyl]spiro[2-benzofuran-3,3'-pyrrolidine]-1-one Chemical compound C1=CC(OC(F)(F)F)=CC=C1SC1(C(=O)N2CC3(CC2)C2=CC=CC=C2C(=O)O3)CC1 GMMUWWOAGPQJAM-UHFFFAOYSA-N 0.000 claims 1
- 125000004605 1,2,3,4-tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims 1
- DZLCJULGPKUTBL-UHFFFAOYSA-N 1,3,3a,4,5,9b-hexahydrobenzo[e]isoindol-2-yl-(1-phenylsulfanylcyclopropyl)methanone Chemical compound C1C2CCC3=CC=CC=C3C2CN1C(=O)C1(SC=2C=CC=CC=2)CC1 DZLCJULGPKUTBL-UHFFFAOYSA-N 0.000 claims 1
- AFUKREKRACCNKC-UHFFFAOYSA-N 2,3,3a,4,5,9b-hexahydro-1h-benzo[e]isoindole Chemical compound C1=CC=C2C3CNCC3CCC2=C1 AFUKREKRACCNKC-UHFFFAOYSA-N 0.000 claims 1
- HXJSHSBBPDVMDI-UHFFFAOYSA-N 3,3a,4,9b-tetrahydro-1h-chromeno[3,4-c]pyrrol-2-yl-(1-phenylsulfanylcyclopropyl)methanone Chemical compound C1C2COC3=CC=CC=C3C2CN1C(=O)C1(SC=2C=CC=CC=2)CC1 HXJSHSBBPDVMDI-UHFFFAOYSA-N 0.000 claims 1
- YNDBVTREHJJWAT-UHFFFAOYSA-N 3,4,4a,5,6,7,8,8a-octahydro-2h-quinolin-1-yl-[1-(4-chlorophenyl)sulfanylcyclopropyl]methanone Chemical compound C1=CC(Cl)=CC=C1SC1(C(=O)N2C3CCCCC3CCC2)CC1 YNDBVTREHJJWAT-UHFFFAOYSA-N 0.000 claims 1
- DJNGUNYUJSDHND-UHFFFAOYSA-N 3,4-dihydro-1h-isoquinolin-2-yl-(1-phenylsulfanylcyclopropyl)methanone Chemical compound C1CC2=CC=CC=C2CN1C(=O)C1(SC=2C=CC=CC=2)CC1 DJNGUNYUJSDHND-UHFFFAOYSA-N 0.000 claims 1
- IVTKVVCRDWLNKG-UHFFFAOYSA-N 4,5,7,7a-tetrahydro-3ah-thieno[2,3-c]pyridin-6-yl-(1-phenylsulfanylcyclopropyl)methanone Chemical compound C1CC2C=CSC2CN1C(=O)C1(SC=2C=CC=CC=2)CC1 IVTKVVCRDWLNKG-UHFFFAOYSA-N 0.000 claims 1
- VOHNTQPXXJRRHW-UHFFFAOYSA-N 5,7-dihydro-4h-thieno[2,3-c]pyridin-6-yl-(1-phenylsulfanylcyclopropyl)methanone Chemical compound C1CC=2C=CSC=2CN1C(=O)C1(SC=2C=CC=CC=2)CC1 VOHNTQPXXJRRHW-UHFFFAOYSA-N 0.000 claims 1
- 206010002383 Angina Pectoris Diseases 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims 1
- 208000028698 Cognitive impairment Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 206010070901 Diabetic dyslipidaemia Diseases 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 206010049287 Lipodystrophy acquired Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 208000018262 Peripheral vascular disease Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- IXLKGMHWBMIPDZ-GOSISDBHSA-N [(1s)-1-(hydroxymethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-(1-phenylsulfanylcyclopropyl)methanone Chemical compound N1([C@@H](C2=CC=CC=C2CC1)CO)C(=O)C1(SC=2C=CC=CC=2)CC1 IXLKGMHWBMIPDZ-GOSISDBHSA-N 0.000 claims 1
- BTCNEIUGAWMUBQ-HUUCEWRRSA-N [(4ar,8as)-3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl]-[1-(4-chlorophenyl)sulfanylcyclopropyl]methanone Chemical compound C1=CC(Cl)=CC=C1SC1(C(=O)N2C[C@H]3CCCC[C@@H]3CC2)CC1 BTCNEIUGAWMUBQ-HUUCEWRRSA-N 0.000 claims 1
- CVFQHONHWKFKRZ-UHFFFAOYSA-N [1-(4-chlorophenyl)sulfanylcyclopropyl]-(3-phenylpiperazin-1-yl)methanone Chemical compound C1=CC(Cl)=CC=C1SC1(C(=O)N2CC(NCC2)C=2C=CC=CC=2)CC1 CVFQHONHWKFKRZ-UHFFFAOYSA-N 0.000 claims 1
- QNFLODIDAIIVBY-UHFFFAOYSA-N [1-(4-chlorophenyl)sulfanylcyclopropyl]-(3-pyridin-2-ylpyrrolidin-1-yl)methanone Chemical compound C1=CC(Cl)=CC=C1SC1(C(=O)N2CC(CC2)C=2N=CC=CC=2)CC1 QNFLODIDAIIVBY-UHFFFAOYSA-N 0.000 claims 1
- ONBSHJJVSBHMQA-UHFFFAOYSA-N [1-(4-chlorophenyl)sulfanylcyclopropyl]-(3-pyridin-4-ylpyrrolidin-1-yl)methanone Chemical compound C1=CC(Cl)=CC=C1SC1(C(=O)N2CC(CC2)C=2C=CN=CC=2)CC1 ONBSHJJVSBHMQA-UHFFFAOYSA-N 0.000 claims 1
- HEXZORPQMGUHAJ-UHFFFAOYSA-N [1-(4-chlorophenyl)sulfanylcyclopropyl]-[3-(3-fluorophenyl)pyrrolidin-1-yl]methanone Chemical compound FC1=CC=CC(C2CN(CC2)C(=O)C2(CC2)SC=2C=CC(Cl)=CC=2)=C1 HEXZORPQMGUHAJ-UHFFFAOYSA-N 0.000 claims 1
- WPBXRCGYVUUKSW-UHFFFAOYSA-N [1-(4-chlorophenyl)sulfanylcyclopropyl]-spiro[1h-2-benzofuran-3,3'-pyrrolidine]-1'-ylmethanone Chemical compound C1=CC(Cl)=CC=C1SC1(C(=O)N2CC3(CC2)C2=CC=CC=C2CO3)CC1 WPBXRCGYVUUKSW-UHFFFAOYSA-N 0.000 claims 1
- VWASVTOLPDBAJG-UHFFFAOYSA-N [1-[4-(4-fluorophenyl)phenyl]sulfanylcyclopropyl]-spiro[1h-2-benzofuran-3,3'-pyrrolidine]-1'-ylmethanone Chemical compound C1=CC(F)=CC=C1C(C=C1)=CC=C1SC1(C(=O)N2CC3(CC2)C2=CC=CC=C2CO3)CC1 VWASVTOLPDBAJG-UHFFFAOYSA-N 0.000 claims 1
- KCINEKNNHYGGPH-UHFFFAOYSA-N [3-(3-fluorophenyl)pyrrolidin-1-yl]-(1-phenylsulfanylcyclopropyl)methanone Chemical compound FC1=CC=CC(C2CN(CC2)C(=O)C2(CC2)SC=2C=CC=CC=2)=C1 KCINEKNNHYGGPH-UHFFFAOYSA-N 0.000 claims 1
- DIWAYWYQMFGEIX-UHFFFAOYSA-N [3-(4-chlorophenyl)pyrrolidin-1-yl]-[1-(4-chlorophenyl)sulfanylcyclopropyl]methanone Chemical compound C1=CC(Cl)=CC=C1SC1(C(=O)N2CC(CC2)C=2C=CC(Cl)=CC=2)CC1 DIWAYWYQMFGEIX-UHFFFAOYSA-N 0.000 claims 1
- QJEWBKDCLCTGLS-UHFFFAOYSA-N [3-(hydroxymethyl)-4-(2-hydroxyphenyl)pyrrolidin-1-yl]-(1-phenylsulfanylcyclopropyl)methanone Chemical compound OCC1CN(C(=O)C2(CC2)SC=2C=CC=CC=2)CC1C1=CC=CC=C1O QJEWBKDCLCTGLS-UHFFFAOYSA-N 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 229960002478 aldosterone Drugs 0.000 claims 1
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 208000020346 hyperlipoproteinemia Diseases 0.000 claims 1
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 208000006132 lipodystrophy Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000008816 organ damage Effects 0.000 claims 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 0 *C(*)(C(N1CC[U]CC1)=O)I* Chemical compound *C(*)(C(N1CC[U]CC1)=O)I* 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58256104P | 2004-06-24 | 2004-06-24 | |
| PCT/US2005/022412 WO2006002350A1 (en) | 2004-06-24 | 2005-06-23 | Amido compounds and their use as pharmaceuticals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008504279A JP2008504279A (ja) | 2008-02-14 |
| JP2008504279A5 true JP2008504279A5 (enExample) | 2008-08-07 |
Family
ID=35782142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007518300A Withdrawn JP2008504279A (ja) | 2004-06-24 | 2005-06-23 | アミド化合物およびその医薬としての使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060009491A1 (enExample) |
| EP (1) | EP1773773A4 (enExample) |
| JP (1) | JP2008504279A (enExample) |
| CA (1) | CA2589565A1 (enExample) |
| WO (1) | WO2006002350A1 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7880001B2 (en) * | 2004-04-29 | 2011-02-01 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| US8415354B2 (en) | 2004-04-29 | 2013-04-09 | Abbott Laboratories | Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US20100222316A1 (en) | 2004-04-29 | 2010-09-02 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| TWI350168B (en) | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| US20050288338A1 (en) * | 2004-06-24 | 2005-12-29 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
| JP2008504278A (ja) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
| US8071624B2 (en) * | 2004-06-24 | 2011-12-06 | Incyte Corporation | N-substituted piperidines and their use as pharmaceuticals |
| US20050288317A1 (en) * | 2004-06-24 | 2005-12-29 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
| JP2008504280A (ja) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | ２−メチルプロパンアミドおよびその医薬としての使用 |
| WO2006020598A2 (en) * | 2004-08-10 | 2006-02-23 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| CA2585797C (en) * | 2004-11-10 | 2015-01-06 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
| US8110581B2 (en) | 2004-11-10 | 2012-02-07 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
| CN101103016A (zh) * | 2004-11-18 | 2008-01-09 | 因塞特公司 | 11-β羟基类固醇脱氢酶1型抑制剂及其使用方法 |
| US20090192198A1 (en) | 2005-01-05 | 2009-07-30 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| CA2594098C (en) | 2005-01-05 | 2014-04-01 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US8198331B2 (en) | 2005-01-05 | 2012-06-12 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| AU2006203918B2 (en) * | 2005-01-05 | 2011-05-19 | Abbvie Inc. | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| JP5140577B2 (ja) * | 2005-03-31 | 2013-02-06 | タケダ カリフォルニア インコーポレイテッド | ヒドロキシステロイドデヒドロゲナーゼ阻害剤 |
| CA2621255A1 (en) * | 2005-09-21 | 2007-04-05 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| WO2007067504A2 (en) * | 2005-12-05 | 2007-06-14 | Incyte Corporation | Lactam compounds and methods of using the same |
| WO2007084314A2 (en) * | 2006-01-12 | 2007-07-26 | Incyte Corporation | MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| TW200804341A (en) * | 2006-01-31 | 2008-01-16 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| EP1981848A2 (en) | 2006-02-07 | 2008-10-22 | Wyeth | 11-beta hsd1 inhibitors |
| US20070213311A1 (en) * | 2006-03-02 | 2007-09-13 | Yun-Long Li | Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| WO2007103719A2 (en) * | 2006-03-03 | 2007-09-13 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| EP2018378A2 (en) * | 2006-05-17 | 2009-01-28 | Incyte Corporation | Heterocyclic inhibitors of 11-b hydroxyl steroid dehydrogenase type i and methods of using the same |
| CL2008001839A1 (es) | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. |
| JP5736098B2 (ja) | 2007-08-21 | 2015-06-17 | アッヴィ・インコーポレイテッド | 中枢神経系障害を治療するための医薬組成物 |
| ATE506359T1 (de) | 2007-11-30 | 2011-05-15 | Bayer Schering Pharma Ag | Heteroaryl-substituierte piperidine |
| EP2398771B1 (en) | 2009-02-18 | 2015-07-29 | Boehringer Ingelheim International GmbH | Heterocyclic compounds which modulate the cb2 receptor |
| DE102009014484A1 (de) | 2009-03-23 | 2010-09-30 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
| DE102009022896A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
| DE102009022894A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
| DE102009022892A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
| ES2350077B1 (es) | 2009-06-04 | 2011-11-04 | Laboratorios Salvat, S.A. | Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1. |
| WO2011058193A1 (en) | 2009-11-16 | 2011-05-19 | Mellitech | [1,5]-diazocin derivatives |
| WO2011088015A1 (en) * | 2010-01-15 | 2011-07-21 | Boehringer Ingelheim International Gmbh | Compounds which modulate the cb2 receptor |
| WO2012012307A1 (en) | 2010-07-22 | 2012-01-26 | Boehringer Ingelheim International Gmbh | Sulfonyl compounds which modulate the cb2 rece |
| EP2803668A1 (en) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles |
| EP3235813A1 (en) | 2016-04-19 | 2017-10-25 | Cidqo 2012, S.L. | Aza-tetra-cyclo derivatives |
| CN110357833B (zh) | 2019-06-03 | 2022-05-24 | 杭州维坦医药科技有限公司 | 芳杂乙酰胺类衍生物及其制备和应用 |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL262366A (enExample) * | 1960-03-14 | |||
| US3201466A (en) * | 1963-03-08 | 1965-08-17 | Gulf Oil Corp | Substituted cyclopropanecarboxanilide herbicides |
| US3849403A (en) * | 1968-04-29 | 1974-11-19 | American Home Prod | 2,3,4,5-tetrahydro-1,1,5,5-tetrasubstituted-1h-3-benzazepines |
| DE2114420A1 (de) * | 1971-03-25 | 1972-10-05 | Merck Patent Gmbh, 6100 Darmstadt | Substituierte Phenylalkanol-Derivate und Verfahren zu ihrer Herstellung |
| US3923350A (en) * | 1974-03-11 | 1975-12-02 | Commercial Metals Company | Precision bearing assembly |
| GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
| US3933829A (en) * | 1974-08-22 | 1976-01-20 | John Wyeth & Brother Limited | 4-Aminoquinoline derivatives |
| TR18917A (tr) * | 1974-10-31 | 1977-12-09 | Ciba Geigy Ag | 1-(bis-triflormetilfenil)-2-oksopirolidin-4-karbonik asitleri ve bunlarin tuerevleri |
| FR2312247A1 (fr) * | 1975-05-30 | 1976-12-24 | Parcor | Derives de la thieno-pyridine, leur procede de preparation et leurs applications |
| US4145435A (en) * | 1976-11-12 | 1979-03-20 | The Upjohn Company | 2-aminocycloaliphatic amide compounds |
| US4439606A (en) * | 1982-05-06 | 1984-03-27 | American Cyanamid Company | Antiatherosclerotic 1-piperazinecarbonyl compounds |
| US4701459A (en) * | 1986-07-08 | 1987-10-20 | Bristol-Myers Company | 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation |
| US5206240A (en) * | 1989-12-08 | 1993-04-27 | Merck & Co., Inc. | Nitrogen-containing spirocycles |
| US5852029A (en) * | 1990-04-10 | 1998-12-22 | Israel Institute For Biological Research | Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| FR2672213B1 (fr) * | 1991-02-05 | 1995-03-10 | Sanofi Sa | Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres. |
| FR2678272B1 (fr) * | 1991-06-27 | 1994-01-14 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
| DE4234295A1 (de) * | 1992-10-12 | 1994-04-14 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| FR2705343B1 (fr) * | 1993-05-17 | 1995-07-21 | Fournier Ind & Sante | Dérivés de beta,beta-diméthyl-4-pipéridineéthanamine, leur procédé de préparation et leur utilisation en thérapeutique. |
| DE9403308U1 (de) * | 1994-02-28 | 1994-04-28 | INA Wälzlager Schaeffler KG, 91074 Herzogenaurach | Ausgleichsgetriebe für ein Kraftfahrzeug |
| FR2724656B1 (fr) * | 1994-09-15 | 1996-12-13 | Adir | Nouveaux derives du benzopyranne, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US5693567A (en) * | 1995-06-07 | 1997-12-02 | Xerox Corporation | Separately etching insulating layer for contacts within array and for peripheral pads |
| FR2736053B1 (fr) * | 1995-06-28 | 1997-09-19 | Sanofi Sa | Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
| GB9517622D0 (en) * | 1995-08-29 | 1995-11-01 | Univ Edinburgh | Regulation of intracellular glucocorticoid concentrations |
| GB9604311D0 (en) * | 1996-02-29 | 1996-05-01 | Merck & Co Inc | Inhibitors of farnesyl-protein transferase |
| GB9600235D0 (en) * | 1996-01-05 | 1996-03-06 | Pfizer Ltd | Therapeutic agents |
| NZ334389A (en) * | 1996-08-28 | 2001-05-25 | Ube Industries | Cyclic amine derivatives |
| ZA979781B (en) * | 1996-11-14 | 1998-06-08 | Akzo Nobel Nv | Piperidine derivatives. |
| NZ506574A (en) * | 1998-02-27 | 2003-06-30 | Sankyo Co | Cyclic amino derivative having a sulphinyl, sulphonyl or disulphanyl group useful in the treatment of thrombosis or embolism |
| ES2165274B1 (es) * | 1999-06-04 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
| AU1413301A (en) * | 1999-11-17 | 2001-05-30 | Sumitomo Pharmaceuticals Company, Limited | Diabetic remedy containing dipiperazine derivative |
| TWI224597B (en) * | 1999-12-03 | 2004-12-01 | Ono Pharmaceutical Co | Triazaspiro[5.5]undecane derivatives and a medicine containing the derivatives as an active ingredient |
| US7294637B2 (en) * | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
| US7102009B2 (en) * | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
| WO2003000657A1 (en) * | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| US6547958B1 (en) * | 2001-07-13 | 2003-04-15 | Chevron U.S.A. Inc. | Hydrocarbon conversion using zeolite SSZ-59 |
| US7074788B2 (en) * | 2001-11-22 | 2006-07-11 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| PE20030701A1 (es) * | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| US6818772B2 (en) * | 2002-02-22 | 2004-11-16 | Abbott Laboratories | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| GB0213715D0 (en) * | 2002-06-14 | 2002-07-24 | Syngenta Ltd | Chemical compounds |
| US20040072802A1 (en) * | 2002-10-09 | 2004-04-15 | Jingwu Duan | Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha |
| MXPA05003632A (es) * | 2002-10-11 | 2005-06-03 | Astrazeneca Ab | Derivados de piperidina 1, 4-disustituidos y su uso como inhibidores de 11-beta-hidroesteroide deshidrogenasa humana de tipo 1 (11betahsd1). |
| US20060019977A1 (en) * | 2002-10-18 | 2006-01-26 | Ono Pharmaceutical Co., Ltd. | Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| EP1683797A1 (en) * | 2003-11-13 | 2006-07-26 | Ono Pharmaceutical Co., Ltd. | Heterocyclic spiro compound |
| TWI350168B (en) * | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| BRPI0512213A (pt) * | 2004-06-16 | 2008-02-19 | Wyeth Corp | método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto |
| JP2008504278A (ja) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
| US20050288317A1 (en) * | 2004-06-24 | 2005-12-29 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
| US8071624B2 (en) * | 2004-06-24 | 2011-12-06 | Incyte Corporation | N-substituted piperidines and their use as pharmaceuticals |
| US20050288338A1 (en) * | 2004-06-24 | 2005-12-29 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
| JP2008504280A (ja) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | ２−メチルプロパンアミドおよびその医薬としての使用 |
| WO2006020598A2 (en) * | 2004-08-10 | 2006-02-23 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| CA2585797C (en) * | 2004-11-10 | 2015-01-06 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
| CN101103016A (zh) * | 2004-11-18 | 2008-01-09 | 因塞特公司 | 11-β羟基类固醇脱氢酶1型抑制剂及其使用方法 |
| AU2006203918B2 (en) * | 2005-01-05 | 2011-05-19 | Abbvie Inc. | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| BRPI0609062A2 (pt) * | 2005-03-03 | 2010-02-17 | F. Hofmann-La Roche Ag | composição farmacêutica, compostos, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por inibidores de deidrogenase de hidroxiesteróide-11ß e utilização dos compostos |
| CA2621255A1 (en) * | 2005-09-21 | 2007-04-05 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| WO2007067504A2 (en) * | 2005-12-05 | 2007-06-14 | Incyte Corporation | Lactam compounds and methods of using the same |
| WO2007084314A2 (en) * | 2006-01-12 | 2007-07-26 | Incyte Corporation | MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| TW200804341A (en) * | 2006-01-31 | 2008-01-16 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| US20070213311A1 (en) * | 2006-03-02 | 2007-09-13 | Yun-Long Li | Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| WO2007103719A2 (en) * | 2006-03-03 | 2007-09-13 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| EP2013163A1 (en) * | 2006-05-01 | 2009-01-14 | Incyte Corporation | Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 |
| EP2018378A2 (en) * | 2006-05-17 | 2009-01-28 | Incyte Corporation | Heterocyclic inhibitors of 11-b hydroxyl steroid dehydrogenase type i and methods of using the same |
| CL2008001839A1 (es) * | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. |
-
2005
- 2005-06-23 CA CA002589565A patent/CA2589565A1/en not_active Abandoned
- 2005-06-23 EP EP05766841A patent/EP1773773A4/en not_active Withdrawn
- 2005-06-23 US US11/159,488 patent/US20060009491A1/en not_active Abandoned
- 2005-06-23 WO PCT/US2005/022412 patent/WO2006002350A1/en not_active Ceased
- 2005-06-23 JP JP2007518300A patent/JP2008504279A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008504279A5 (enExample) | ||
| JP2008504278A5 (enExample) | ||
| JP2008504274A5 (enExample) | ||
| RU2497813C2 (ru) | 4-(4-циано-2-тиоарил)-дигидропиримидиноны и их применение | |
| RU2412192C2 (ru) | Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2 | |
| ES2312472T3 (es) | Compuesto alifatico de cinco miembros de anillo que contiene nitrogeno. | |
| JP2007536252A5 (enExample) | ||
| ES2569327T3 (es) | Promotores de la apoptosis que contienen N-acilsulfonamida | |
| RU2012112151A (ru) | Соединения как модуляторы тирозинкиназы | |
| JP2023123854A5 (enExample) | ||
| JP2012515761A5 (enExample) | ||
| JP2017522374A5 (enExample) | ||
| RU2009140465A (ru) | Имидазохинолины с иммуномодулирующими свойствами | |
| RU2004122114A (ru) | Химические соединения | |
| RU2011107437A (ru) | Ингибиторы кинуренин-3-моноксигеназы | |
| WO2005113542B1 (en) | N-cyclic sulfonamido inhibitors of gamma secretase | |
| RU2005102004A (ru) | Замещенные хинолины как антагонисты рецептора ccr5 | |
| CA2487489A1 (en) | Mitotic kinesin inhibitors | |
| HK1245791A1 (zh) | 用於雄激素受体的靶向降解的化合物和方法 | |
| RU2010106974A (ru) | Ариловые эфиры пирролидина в качестве антагонистов рецепторов nk3 | |
| CA2587800A1 (en) | Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
| RU2010108687A (ru) | Ариловые эфиры пирролидина в качестве антагонистов рецепторов nk3 | |
| RU2008126391A (ru) | Производные 1,5-замещенного индол-2-иламида | |
| HRP20151064T1 (hr) | Amido spojevi i njihova upotreba kao farmaceutski proizvodi | |
| RU2011146872A (ru) | Производные пролина в качестве ингибиторов катепсина |